eClinical Solutions Market Analysis 2018 | Growth by Top Companies:BioClinica Inc., CRF Health, DATATRAK International Inc., eClinical Solutions Inc., MaxisIT Inc., Medidata Solutions Inc., Merge Healthcare Inc., OmniComm Systems Inc.

eClinical solutions is used to improve the clinical development process through data management and data analysis. It offers total transparency and utilization of the clinical and operational data by providing data management software and customized data management services, including electronic data capture (EDC), clinical reporting, clinical data repository platform and data management and standardization. The advantages and applications of eClinical software allows users to analyze, manage, integrate, and standardize all their clinical and operational data with the help of integrated advanced visualization and analytical capabilities. Software such as clinical trial managements system (CTMS) help users to comply with government regulations, patient management, investigator management, budgeting, and adverse event reporting system among others.

Ask Sample Copy @ www.coherentmarketinsights.com/insight/request-sample/782

Increasing R&D by biotechnology and pharmaceutical companies is expected to drive growth of the market

Various software application of clinical solutions are gaining acceptability in clinical trials, which is supposed to be the key factor driving growth of the eClinical solutions market. The other factors such as increasing government funding and rising R&D programs by biopharma and pharmaceutical companies are expected to produce new products, which will further boost growth in eClinical solutions market. Innovations and technological advances in the field of software solutions will help in fuelling growth in the market over the forecast period. According to U.S. National Library of Medicine, in last 20 years, there has been a significant increase in the number of new clinical trials registered every year.

Extensive research and development has led the companies to outsource R&D activities from other cheaper avenues. The independent service providers such as CROs are committed to provide high quality and timely data, adhering to the regulatory guidleines and post-approval regulatory requirements, which in turn facilitates in lowering the overall cost. For instance, in 2011, Pfizer entered into an agreement with Parexel and Icon. Under this agreement, Parexel provided Pfizer with a range of clinical development services for five years.

Ask for customization: www.coherentmarketinsights.com/insight/request-customizat...

Key Takeaways of the eClinical Solutions Market:

The global eClinical solutions market is expected to exhibit a CAGR of 11.2% over the forecast period, owing to growing adoption of software solutions during clinical research and rising government funding to support clinical trials.

Among deployment types, the cloud-based segment is estimated to hold the dominant position, as it is ideal for complex and multisite clinical studies

Among product types, the clinical data management system (CDMS) is estimated to hold major share due to its high quality, reliable, and statistically sound data

Among end users, pharmaceutical and biopharmaceutical companies segment holds a dominant position in the eClinical solutions market, owing to increasing usage of software for drug development

Asia Pacific eClinical solutions market is expected to exhibit significant growth, owing to increasing number of clinical trials being performed.

Place a Purchase Order For “eClinical solutions Market (Single User License) at: https://www.coherentmarketinsights.com/insight/buy-now/782

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154
#3200

This release was published on openPR.